Vatalanib
- Generic Name
- Vatalanib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H15ClN4
- CAS Number
- 212141-54-3
- Unique Ingredient Identifier
- 5DX9U76296
- Background
Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under investigation for the treatment of solid tumors.
- Indication
Used in combination with first- and second-line chemotherapy for the treatment of metastatic colorectal cancer and non-small cell lung cancer (NSCLC).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath